HIV1 V3 loop hypermutability is enhanced by the guanine usage bias in the part of env gene coding for it

In Silico Biology

Volumn 9, Issue 4, 2009, Pages 255-269

  Khrustalev, Vladislav Victorovich ^a,b  

^a BELARUSIAN STATE MEDICAL UNIVERSITY   (Belarus)

^b NONE   (Belarus)

Author keywords

APOBEC; Codon usage bias; Fast AIDS progressors; Gp120; Guanine usage; HIV1; HIV2; Immune escaping; Mutational pressure; Slow AIDS progressors; V3 loop

Indexed keywords

ENVELOPE PROTEIN; GLYCOPROTEIN GP 120; GUANINE;

ARTICLE; CODON; COMPUTER MODEL; CONTROLLED STUDY; GENE INSERTION SEQUENCE; GENE SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MOLECULAR EVOLUTION; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; UNINDEXED SEQUENCE; VIRUS GENE; VIRUS STRAIN;

ALGORITHMS; AMINO ACID SEQUENCE; BASE COMPOSITION; BASE SEQUENCE; CODON; GENES, ENV; GUANINE; HIV ENVELOPE PROTEIN GP120; HIV-1; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDE FRAGMENTS;

EID: 70449380016     PISSN: 14343207     EISSN: None     Source Type: Journal    
DOI: 10.3233/ISB-2009-0406     Document Type: Article

References (18)

1. Berkhout, B. and van Hemert, F. J. (1994). The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteins. Nucleic Acids Res. 22, 1705-1711.
2. Berkhout, B. and de Ronde, A. (2004). APOBEC3G versus reverse transcriptase in the generation of HIV-1 drug-resistance mutations. AIDS 18, 1861-1863.
3. Bourara, K., Liegler, T. J. and Grant, R. M. (2007). Target cell APOBEC3C can induce limited G-to-A mutation in HIV-1. PLoS Pathog. 3 e153.
4. Brengel-Pesce, K., Morand, P., Innocenti-Francillard, P., Chanzy, B., Bourgeat, M. J., Leclercq, P., Micoud, M. and Seigneurin, J. M. (1996). Genetic and biological analysis of variants derived from the cerebrospinal fluid of HIV type 1 subtype B- and D- infected patients with and without AIDS dementia complex. AIDS Res. Hum. Retroviruses 12, 1643-1645.
5. Dang, Y., Wang, X., Esselman, W. J. and Zheng, Y. H. (2006). Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family. J. Virol. 80, 10522-10533.
6. Izumi, T., Shirakawa, K. and Takaori-Kondo, A. (2008). Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy. Mini. Rev. Med. Chem. 8, 231-238.
7. Khrustalev, V. V. and Barkovsky, E. V. (2008). An in-silico study of alphaherpesviruses ICP0 genes: Positive selection or strong mutational GC-pressure? IUBMB Life 60, 456-460.
8. Liddament, M. T., Brown, W. L., Schumacher, A. J. and Harris, R. S. (2004). APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr. Biol. 14, 1385-1391.
9. Moore, J. P. and Ho, D. D. (1993). Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 67, 863-875.
10. Pillai, S. K., Wong, J. K. and Barbour, J. D. (2008). Turning up the volume on mutational pressure: Is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3). Retrovirology 5, 26.
11. Ripamonti, C., Leitner, T., Laurén, A., Karlsson, I., Pastore, A., Cavarelli, M., Antonsson, L., Plebani, A., Fenyö, E. M. and Scarlatti, G. (2007). Biological and genetic evolution of HIV type 1 in two siblings with different patterns of disease progression. AIDS Res. Hum. Retroviruses 23, 1531-1540.
12. Sankalé J. L., de la Tour, R. S., Renjifo, B., Siby, T., Mboup, S., Marlink, R. G., Essex, M. E. and Kanki, P. J. (1995). Intrapatient variability of the human immunodeficiency virus type 2 envelope V3 loop. AIDS Res. Hum. Retroviruses 11, 617-623.
13. Spenlehauer, C. Saragosti, S., Fleury, J. A. H., Kirn, A., Aubertin, A. M. and Moog, C. (1998). Study of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell-line-adapted strains of human immunodeficiency virus type 1. J. Virol. 72, 9855-9864.
14. Tamura, K., Dudley, J., Nei, M. and Kumar, S. (2007). MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24, 1596-1599.
15. Tsibris, A. M., Sagar, M., Gulick, R. M., Su, Z., Hughes, M., Greaves, W., Subramanian, M., Flexner, C., Giguel, F., Leopold, K. E., Coakley, E. and Kuritzkes, D. R. (2008). In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject. J. Virol. 82, 8210-8214.
16. Williamson, S. (2003). Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression. Mol. Biol. Evol. 20, 1318-1325.
17. Yamaguchi, Y. and Gojobori, T. (1997). Evolutionary mechanisms and population dynamics of the third variable envelope region of HIV within single hosts. Proc. Natl. Acad. Sci. USA 94, 1264-1269.
18. Yang,W., Bielawski, J. P. and Yang, Z. (2003). Widespread adaptive evolution in the human immunodeficiency virus type 1 genome. J. Mol. Evol. 57, 212-221.